144 related articles for article (PubMed ID: 17082597)
1. TIRC7 inhibits T cell proliferation by modulation of CTLA-4 expression.
Bulwin GC; Heinemann T; Bugge V; Winter M; Lohan A; Schlawinsky M; Schulze A; Wälter S; Sabat R; Schülein R; Wiesner B; Veh RW; Löhler J; Blumberg RS; Volk HD; Utku N
J Immunol; 2006 Nov; 177(10):6833-41. PubMed ID: 17082597
[TBL] [Abstract][Full Text] [Related]
2. Adiponectin is a negative regulator of antigen-activated T cells.
Wilk S; Scheibenbogen C; Bauer S; Jenke A; Rother M; Guerreiro M; Kudernatsch R; Goerner N; Poller W; Elligsen-Merkel D; Utku N; Magrane J; Volk HD; Skurk C
Eur J Immunol; 2011 Aug; 41(8):2323-32. PubMed ID: 21538348
[TBL] [Abstract][Full Text] [Related]
3. TIRC7 deficiency causes in vitro and in vivo augmentation of T and B cell activation and cytokine response.
Utku N; Boerner A; Tomschegg A; Bennai-Sanfourche F; Bulwin GC; Heinemann T; Loehler J; Blumberg RS; Volk HD
J Immunol; 2004 Aug; 173(4):2342-52. PubMed ID: 15294947
[TBL] [Abstract][Full Text] [Related]
4. Differential role of CTLA-4 in regulation of resting memory versus naive CD4 T cell activation.
Metz DP; Farber DL; Taylor T; Bottomly K
J Immunol; 1998 Dec; 161(11):5855-61. PubMed ID: 9834064
[TBL] [Abstract][Full Text] [Related]
5. The cell-cell adhesion molecule carcinoembryonic antigen-related cellular adhesion molecule 1 inhibits IL-2 production and proliferation in human T cells by association with Src homology protein-1 and down-regulates IL-2 receptor.
Chen CJ; Shively JE
J Immunol; 2004 Mar; 172(6):3544-52. PubMed ID: 15004155
[TBL] [Abstract][Full Text] [Related]
6. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes.
Linsley PS; Greene JL; Tan P; Bradshaw J; Ledbetter JA; Anasetti C; Damle NK
J Exp Med; 1992 Dec; 176(6):1595-604. PubMed ID: 1334116
[TBL] [Abstract][Full Text] [Related]
7. Diversity of clonal T cell proliferation is mediated by differential expression of CD152 (CTLA-4) on the cell surface of activated individual T lymphocytes.
Maszyna F; Hoff H; Kunkel D; Radbruch A; Brunner-Weinzierl MC
J Immunol; 2003 Oct; 171(7):3459-66. PubMed ID: 14500641
[TBL] [Abstract][Full Text] [Related]
8. Activation-induced expression of carcinoembryonic antigen-cell adhesion molecule 1 regulates mouse T lymphocyte function.
Nakajima A; Iijima H; Neurath MF; Nagaishi T; Nieuwenhuis EE; Raychowdhury R; Glickman J; Blau DM; Russell S; Holmes KV; Blumberg RS
J Immunol; 2002 Feb; 168(3):1028-35. PubMed ID: 11801635
[TBL] [Abstract][Full Text] [Related]
9. Low CD86 expression in the nonobese diabetic mouse results in the impairment of both T cell activation and CTLA-4 up-regulation.
Dahlén E; Hedlund G; Dawe K
J Immunol; 2000 Mar; 164(5):2444-56. PubMed ID: 10679081
[TBL] [Abstract][Full Text] [Related]
10. CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression.
Carreno BM; Bennett F; Chau TA; Ling V; Luxenberg D; Jussif J; Baroja ML; Madrenas J
J Immunol; 2000 Aug; 165(3):1352-6. PubMed ID: 10903737
[TBL] [Abstract][Full Text] [Related]
11. TIRC7 pathway as a target for preventing allograft rejection.
Tamura A; Milford EL; Utku N
Drug News Perspect; 2005 Mar; 18(2):103-8. PubMed ID: 15883619
[TBL] [Abstract][Full Text] [Related]
12. Blockade of T cell activation using a surface-linked single-chain antibody to CTLA-4 (CD152).
Griffin MD; Hong DK; Holman PO; Lee KM; Whitters MJ; O'Herrin SM; Fallarino F; Collins M; Segal DM; Gajewski TF; Kranz DM; Bluestone JA
J Immunol; 2000 May; 164(9):4433-42. PubMed ID: 10779742
[TBL] [Abstract][Full Text] [Related]
13. Blockade of CTLA-4 signals inhibits Th2-mediated murine chronic graft-versus-host disease by an enhanced expansion of regulatory CD8+ T cells.
Sakurai J; Ohata J; Saito K; Miyajima H; Hirano T; Kohsaka T; Enomoto S; Okumura K; Azuma M
J Immunol; 2000 Jan; 164(2):664-9. PubMed ID: 10623808
[TBL] [Abstract][Full Text] [Related]
14. TIRC7 and HLA-DR axis contributes to inflammation in multiple sclerosis.
Frischer JM; Reindl M; Künz B; Berger T; Schmidt S; Milford EL; Knosp E; Lassmann H; Utku N
Mult Scler; 2014 Aug; 20(9):1171-81. PubMed ID: 24526664
[TBL] [Abstract][Full Text] [Related]
15. CTLA-4+CD8+ T cells that encounter B7-2+ iris pigment epithelial cells express their own B7-2 to achieve global suppression of T cell activation.
Sugita S; Ng TF; Schwartzkopff J; Streilein JW
J Immunol; 2004 Apr; 172(7):4184-94. PubMed ID: 15034031
[TBL] [Abstract][Full Text] [Related]
16. Role of CTLA-4 in the activation of single- and double-positive thymocytes.
Kwon H; Jun HS; Khil LY; Yoon JW
J Immunol; 2004 Dec; 173(11):6645-53. PubMed ID: 15557155
[TBL] [Abstract][Full Text] [Related]
17. Dual effect of CD85/leukocyte Ig-like receptor-1/Ig-like transcript 2 and CD152 (CTLA-4) on cytokine production by antigen-stimulated human T cells.
Saverino D; Merlo A; Bruno S; Pistoia V; Grossi CE; Ciccone E
J Immunol; 2002 Jan; 168(1):207-15. PubMed ID: 11751964
[TBL] [Abstract][Full Text] [Related]
18. CTLA-4 and CD28 mRNA are coexpressed in most T cells after activation. Expression of CTLA-4 and CD28 mRNA does not correlate with the pattern of lymphokine production.
Freeman GJ; Lombard DB; Gimmi CD; Brod SA; Lee K; Laning JC; Hafler DA; Dorf ME; Gray GS; Reiser H
J Immunol; 1992 Dec; 149(12):3795-801. PubMed ID: 1281186
[TBL] [Abstract][Full Text] [Related]
19. TIRC7 inhibits Th1 cells by upregulating the expression of CTLA‑4 and STAT3 in mice with acute graft‑versus‑host disease.
Zhu F; Qiu T; Zhu S; Zhao K; Chen C; Qiao J; Pan B; Yan Z; Chen W; Liu Q; Wu Q; Cao J; Sang W; Zeng L; Sun H; Li Z; Xu K
Oncol Rep; 2020 Jul; 44(1):43-54. PubMed ID: 32319655
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibody specific for TIRC7 induces donor-specific anergy and prevents rejection of cardiac allografts in mice.
Kumamoto Y; Tomschegg A; Bennai-Sanfourche F; Boerner A; Kaser A; Schmidt-Knosalla I; Heinemann T; Schlawinsky M; Blumberg RS; Volk HD; Utku N
Am J Transplant; 2004 Apr; 4(4):505-14. PubMed ID: 15023142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
